In 2013, Nature told the world that NeuroRacer, the first health game from the research lab that would spin out to become Akili Labs, was a game changer. While Akili Labs cofounder and Chief Science ...
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...
A recent study of the video-game-based treatment that focused on adults with ADHD found that EndeavorRx boosted their sustained and selective attention at a rate nearly seven times that of the ...
In the wake of study results showing that its video-game-based treatment for symptoms of attention-deficit/hyperactivity disorder (ADHD) could be highly effective in ...
Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...
Following positive top-line data released in May, Akili Interactive announced it will release its video game treatment for attention deficit hyperactivity disorder to adults who want to use it.
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s ...
Following its recent $30 million fundraise to advance its video game platform for neurological conditions such as attention deficit hyperactivity disorder and Alzheimer’s disease, Akili Interactive ...
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, is presenting pivotal trial data on EndeavorRx ® (AKL-T01) in adolescents ...
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...